March 14 is the day the Oncology Advisory Committee meets, and discusses GERNs drug Imetelstat. It isn't the day the FDA comes out with a yea or nea, as that's June 14. However according to JAMA, 97% of the time the Advisory is positive on a drug, it gets approved.